Kevin F. McLaughlin - 29 Apr 2026 Form 4 Insider Report for Vericel Corp (VCEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 May 2026, 16:06:06 UTC
Prior SEC filing
13 Feb 2026
Next SEC filing
15 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin

Key filing fact

Kevin F. McLaughlin filed Form 4 for Vericel Corp (VCEL) on 01 May 2026.

Key facts

  • This page summarizes Kevin F. McLaughlin's Form 4 filing for Vericel Corp (VCEL).
  • 4 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 01 May 2026, 16:06.

Change

  • Previous filing in this sequence was filed on 13 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001214938 Primary reporting owner

MCLAUGHLIN KEVIN F

Relationship
Director
Address
C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin
Signature date
01 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCEL transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,200
Change %
+21%
Price
Shares after
18,300
Date
29 Apr 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCEL transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
+3,200
Change %
Price
$0.000000*
Shares after
0
Date
29 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,200
Exercise price
Footnotes
F2, F3, F4
VCEL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+8,000
Change %
Price
$0.000000*
Shares after
8,000
Date
29 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,000
Exercise price
$33.43
Footnotes
F5
VCEL transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares
+3,200
Change %
Price
$0.000000*
Shares after
3,200
Date
29 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,200
Exercise price
Footnotes
F2, F4, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025.

Footnote F2

Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

Footnote F3

These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.

Footnote F4

No expiration date for this type of award.

Footnote F5

The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.

Footnote F6

These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .